Cargando…

Economic evaluation of zinc and copper use in treating acute diarrhea in children: A randomized controlled trial

BACKGROUND: The therapeutic effects of zinc and copper in reducing diarrheal morbidity have important cost implications. This health services research study evaluated the cost of treating a child with acute diarrhea in the hospital, the impact of micronutrient supplementation on the mean predicted c...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Archana B, Dhande, Leena A, Rawat, Manwar S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC201016/
https://www.ncbi.nlm.nih.gov/pubmed/14498987
http://dx.doi.org/10.1186/1478-7547-1-7
_version_ 1782120946760417280
author Patel, Archana B
Dhande, Leena A
Rawat, Manwar S
author_facet Patel, Archana B
Dhande, Leena A
Rawat, Manwar S
author_sort Patel, Archana B
collection PubMed
description BACKGROUND: The therapeutic effects of zinc and copper in reducing diarrheal morbidity have important cost implications. This health services research study evaluated the cost of treating a child with acute diarrhea in the hospital, the impact of micronutrient supplementation on the mean predicted costs and its cost-effectiveness as compared to using only standard oral rehydration solution (ORS), from the patient's and government's (providers) perspective. METHODS: Children aged 6 months to 59 months with acute diarrhea were randomly assigned to receive either the intervention or control. The intervention was a daily dose of 40 mg of zinc sulfate and 5 mg of copper sulfate powder dissolved in a liter of standard ORS (n = 102). The control was 50 mg of standard ORS powder dissolved in a liter of standard ORS (n = 98). The cost measures were the total mean cost of treating acute diarrhea, which included the direct medical, the direct non-medical and the indirect costs. The effectiveness measures were the probability of diarrhea lasting ≤ 4 days, the disability adjusted life years (DALYs) and mortality. RESULTS: The mean total cost of treating a child with acute diarrhea was US $14 of which the government incurred an expenditure of 66%. The factors that increased the total were the number of stools before admission (p = 0.01), fever (p = 0.01), increasing grade of dehydration (p = 0.00), use of antibiotics (p = 0.00), use of intra-venous fluids (p = 0.00), hours taken to rehydrate a child (p = 0.00), the amount of oral rehydration fluid used (p = 0.00), presence of any complications (p = 0.00) and the hospital stay (p = 0.00). The supplemented group had a 8% lower cost of treating acute diarrhea, their cost per unit health (diarrhea lasting ≤ 4 days) was 24% less and the incremental cost-effectiveness ratio indicated cost savings (in Rupees) with the intervention [-452; 95%CI (-11306, 3410)]. However these differences failed to reach conventional levels of significance. CONCLUSION: An emphasis on the costs and economic benefits of an alternative therapy is an important aspect of health services research. The cost savings and the attractive cost-effectiveness indicates the need to further assess the role of micronutrients such as zinc and copper in the treatment of acute diarrhea in a larger and more varied population.
format Text
id pubmed-201016
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-2010162003-09-30 Economic evaluation of zinc and copper use in treating acute diarrhea in children: A randomized controlled trial Patel, Archana B Dhande, Leena A Rawat, Manwar S Cost Eff Resour Alloc Research BACKGROUND: The therapeutic effects of zinc and copper in reducing diarrheal morbidity have important cost implications. This health services research study evaluated the cost of treating a child with acute diarrhea in the hospital, the impact of micronutrient supplementation on the mean predicted costs and its cost-effectiveness as compared to using only standard oral rehydration solution (ORS), from the patient's and government's (providers) perspective. METHODS: Children aged 6 months to 59 months with acute diarrhea were randomly assigned to receive either the intervention or control. The intervention was a daily dose of 40 mg of zinc sulfate and 5 mg of copper sulfate powder dissolved in a liter of standard ORS (n = 102). The control was 50 mg of standard ORS powder dissolved in a liter of standard ORS (n = 98). The cost measures were the total mean cost of treating acute diarrhea, which included the direct medical, the direct non-medical and the indirect costs. The effectiveness measures were the probability of diarrhea lasting ≤ 4 days, the disability adjusted life years (DALYs) and mortality. RESULTS: The mean total cost of treating a child with acute diarrhea was US $14 of which the government incurred an expenditure of 66%. The factors that increased the total were the number of stools before admission (p = 0.01), fever (p = 0.01), increasing grade of dehydration (p = 0.00), use of antibiotics (p = 0.00), use of intra-venous fluids (p = 0.00), hours taken to rehydrate a child (p = 0.00), the amount of oral rehydration fluid used (p = 0.00), presence of any complications (p = 0.00) and the hospital stay (p = 0.00). The supplemented group had a 8% lower cost of treating acute diarrhea, their cost per unit health (diarrhea lasting ≤ 4 days) was 24% less and the incremental cost-effectiveness ratio indicated cost savings (in Rupees) with the intervention [-452; 95%CI (-11306, 3410)]. However these differences failed to reach conventional levels of significance. CONCLUSION: An emphasis on the costs and economic benefits of an alternative therapy is an important aspect of health services research. The cost savings and the attractive cost-effectiveness indicates the need to further assess the role of micronutrients such as zinc and copper in the treatment of acute diarrhea in a larger and more varied population. BioMed Central 2003-08-29 /pmc/articles/PMC201016/ /pubmed/14498987 http://dx.doi.org/10.1186/1478-7547-1-7 Text en Copyright © 2003 Patel et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research
Patel, Archana B
Dhande, Leena A
Rawat, Manwar S
Economic evaluation of zinc and copper use in treating acute diarrhea in children: A randomized controlled trial
title Economic evaluation of zinc and copper use in treating acute diarrhea in children: A randomized controlled trial
title_full Economic evaluation of zinc and copper use in treating acute diarrhea in children: A randomized controlled trial
title_fullStr Economic evaluation of zinc and copper use in treating acute diarrhea in children: A randomized controlled trial
title_full_unstemmed Economic evaluation of zinc and copper use in treating acute diarrhea in children: A randomized controlled trial
title_short Economic evaluation of zinc and copper use in treating acute diarrhea in children: A randomized controlled trial
title_sort economic evaluation of zinc and copper use in treating acute diarrhea in children: a randomized controlled trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC201016/
https://www.ncbi.nlm.nih.gov/pubmed/14498987
http://dx.doi.org/10.1186/1478-7547-1-7
work_keys_str_mv AT patelarchanab economicevaluationofzincandcopperuseintreatingacutediarrheainchildrenarandomizedcontrolledtrial
AT dhandeleenaa economicevaluationofzincandcopperuseintreatingacutediarrheainchildrenarandomizedcontrolledtrial
AT rawatmanwars economicevaluationofzincandcopperuseintreatingacutediarrheainchildrenarandomizedcontrolledtrial